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Introduction: The utility of accelerometer-based activity data to identify patients at
risk of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) has not
previously been investigated. The aim of the current study was to determine whether
physical activity is associated with manifesting spontaneous sustained VT/VF requir-
ing emergent defibrillation in patients with an ejection fraction of ≤35%.
Methods: Patients consecutively prescribed a wearable cardioverter defibrillator
(WCD) from April 2015 to May 2018 were included. Shock data and 4 weeks of
physical activity data, beginning with the first week of WCD wear, were analyzed.
Results: Based on the ROC curve outcome generated from 4057 patients, average
daily step count during the first week accurately predicted those patients with
sustained VT/VF compared to those without (shocked (n = 81) vs nonshocked
(n = 3976) area under the curve, c-index = 0.71, 95% CI = 0.65-0.77, P < .001). An
average cutoff of 3637 daily steps during week 1 separated the groups. Patients who
averaged fewer than 3637 steps per day during the first week of WCD use were 4.3
times more likely to experience a shock than those who walked more than 3637
steps per day (OR = 4.29, 95% CI = 2.58-7.15, P < .001).
Discussion: Average daily step counts are lower in WCD patients who manifest
spontaneous VT/VF. Whether these findings represent a causal or correlational rela-
tionship, future studies to encourage a minimum daily step count in high-risk patients
may impact the incidence of sustained VT/VF.
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1 | INTRODUCTION
Physical activity has prognostic value for cardiac patients. Following
a myocardial infarction, patients self-reported activity is a significant
predictor of death.1-3 More objective measures of physical activity,
such as walking speed or results from the 6-minute walk test, are also
predictive of clinical outcomes for cardiac patients.4,5 Many modern
cardiac devices contain accelerometers, allowing for continuous
monitoring of activity. In patients with heart failure, activity data col-
lected from these devices has been used to predict atrial arrhythmias,
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improved ejection fraction, heart failure hospitalization, and
death.5-10
The precision of accelerometer data has allowed investigators to
calculate specific cutoff values of activity associated with adverse car-
diac outcomes. A retrospective study of patients with implantable car-
dioverter defibrillators (ICDs) found that decreased physical activity in
the months following implantation is associated with an increase in
heart failure hospitalization and mortality.6 For every 10 minutes per
day of additional time spent active, there was a 4% risk reduction in a
composite variable of hospitalization and death. Zhao and colleagues
(2017) analyzed activity data from 845 patients with ICDs to deter-
mine whether physical activity could predict cardiac mortality. A cut-
off value of 113 minutes of activity per day was found to successfully
predict cardiac death. In a recent study, accelerometer-based activity
was associated with the risk of atrial arrhythmias.9 Patients who were
active for less than 3.5 hours per day were at a higher risk for subclini-
cal high-rate atrial fibrillation lasting for 6 minutes or longer. These
studies demonstrate the utility of physical activity as a mechanism to
identify patients at risk for cardiac events.
Ventricular arrhythmias are the leading cause of sudden cardiac
death among patients with heart failure. In the months following a
diagnosis of heart failure with reduced ejection fraction, patients are
at an increased risk of arrhythmic death.11,12 The wearable car-
dioverter defibrillator (WCD) is able to detect ventricular tachycardia
(VT) and ventricular fibrillation (VF) and deliver a shock to restore
sinus rhythm (Chung, 2014). Like the ICD, the WCD contains an accel-
erometer capable of continuous activity monitoring. Among patients
with an ICD, self-reported physical exertion is associated with an
increased risk of sustained VT.13 However, when accounting for gen-
eral fitness level, the relationship between sustained ventricular
arrhythmia and physical exertion is strongest among patients who
reported generally lower fitness levels or predominately sedentary
behavior over the 6 months preceding an appropriate shock.14 The
utility of an accelerometer to identify patients at risk of sustained
VT/VF based on physical activity has not been investigated. The aim
of the current study was to determine whether physical activity is
associated with sustained VT/VF requiring emergent defibrillation in
patients with an ejection fraction of ≤35%. Specifically, differences in
daily step count were compared for WCD patients who received a
shock for sustained VT/VF and those who did not.
2 | METHODS
2.1 | Patients
In this retrospective cohort study, we analyzed adult patients who
were consecutively prescribed a WCD in Germany from April 2015 to
May 2018. Consent was obtained from all patients to use their data.
Four weeks of physical activity beginning with the first week of WCD
wear were used for the current study. To be included in the dataset,
patients had to have a minimum threshold of at least 140 hours of
WCD wear during the first week of WCD prescription. Patients were
excluded if they died of unknown death over the prescribed wearing
period, had incomplete data, or withdrawn WCD. Patients were
included in the shocked group in they received an appropriate shock.
Patients who received an inappropriate shock were included in the
nonshocked group.
2.2 | Device description
The WCD (LifeVest, ZOLL, Pittsburgh, PA) automatically detects and
treats sustained VT and VF. The device contains a monitor (about
0.77 kg) worn on a hip holster (or shoulder strap) and an electrode
belt; the latter holds 4 dry electrodes creating 2 surface electrocardio-
gram (ECG) channels, positioned in side-to-side (SS) and front-to-back
(FB) configurations. A three-axis accelerometer in the electrode belt
determines the patient's step count and body position. The chest gar-
ment contains two defibrillation pads on the back and one at the left
anterior part of the chest, close to the apical region of the heart. A
pair of response buttons on the monitor allows a conscious patient to
prevent a potential shock. A description of the WCD technical details
have been reported elsewhere in the literature.15
2.3 | Statistical analysis
Descriptive statistics were used to summarize demographic and shock
data. Activity data, defined as step count, was continuously recorded
for each patient during WCD wear. Average daily step count was cal-
culated each week for 4 consecutive weeks. Data were excluded for
one patient due to their Week 3 step count being an extreme outlier
(z-score = 13). Receiver operating characteristic (ROC) curves were
constructed to determine the optimal cutoff for predicting group
membership (shocked vs nonshocked) using step count during week
1. The Youdin index method was applied to preserve sensitivity and
specificity when identifying the step count cutoff value. A t-test was
used to assess differences in physical activity between the shocked
and nonshocked groups at weeks 2, 3, and 4. A P-value < .05 was con-
sidered statistically significant. All analyses were performed using
SPSS version 25 (IBM SPSS Statistics, IBM Corporation, Armonk, NY).
3 | RESULTS
3.1 | Patients
A total of 5528 patients were screened, 1471 patients were excluded
for incomplete data (n = 97), not meeting minimum age (n = 15) or
WCD hours of wear requirements (n = 677), withdrawn WCD (with-
drawn could be due to several factors including: skin irritation,
noncompliance, insurance reasons) (n = 630), or if they died of
unknown death during the study period (n = 52). In the final sample,
4057 patients were included. Demographic variables for the full sam-
ple, and by group (shocked vs nonshocked) are summarized in Table 1.
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Eighty-one patients (2%) received an appropriate shock for sustained
VT/VF during WCD wear. On average, patients in the shocked group
were older (64, SD = 14 years) than patients in the nonshocked group
(60, SD = 13 years, P = .01). Of the 81 patients who received a shock,
9 (11%) did not survive the shock event.
3.2 | Activity
During week 1, patients in the shocked group had significantly fewer
steps compared to the not-shocked group (Table 1).
Based on the ROC curve outcome, daily step count during week
1 demonstrated good accuracy in predicting group (shocked vs non-
shocked (area under the curve, c-index = .71, 95% CI = .65-.77,
P < .001). The Youdin index was applied and a cutoff daily step count
of 3637 during week 1 was identified with maximum sensitivity and
specificity, 73% and 65%, respectively. In our sample, 36% (n = 1463)
of patients walked fewer than 3637 steps a day during week 1. These
patients were five times more likely to experience a shock than
patients with more than 3637 steps per day during this time period
(OR = 4.91, 95% CI = 3.0-8.05, P < .001).
A logistic regression was performed to predict group membership
from step count; age and WCD indication was univariately associated
with the group and were therefore entered into the model as addi-
tional predictors. A binary variable was created for step count based
on the cutoff of 3637 steps per day during week 1 (ie, greater than
3637 or less than 3637 steps). With age and WCD indication entered
into the model, step count during week 1 remained a significant pre-
dictor of group. In this multivariate analysis, patients who walked
fewer than 3637 steps per day during the first week of WCD pre-
scription were 4.3 times more likely to experience a shock than those
who walked more than 3637 steps per day (OR = 4.29, 95%
CI = 2.58-7.15, P < .001). Step count over the following 3 weeks
remained significantly lower in the shocked group compared to the
nonshocked group (Figure 1).
4 | DISCUSSION
Less physical activity in the first week of WCD use is associated with
shocked VT/VF events in the first month of WCD use. Patients who
received a shock walked nearly half as many steps as patients in the
nonshocked group. A cutoff value of 3637 steps during the first week
of WCD use successfully identified shocked and nonshocked patients,
even after controlling for differences in age between the two groups.
Among patients who were shocked, 73% had fewer than 3637 steps
during week 1.
Previous work has shown the utility of physical activity in
predicting atrial arrhythmias, heart failure hospitalization, and
death.5-10 Results from the present study add to this literature by
demonstrating the utility of accelerometer-acquired activity in
predicting sustained VT/VF in a population of WCD patients with a
low ejection fraction. Furthermore, a clinically meaningful daily step
count has been identified allowing clinicians to set a goal for their
patients to reach a minimum step count of approximately 4000 steps
each day to reduce the likelihood of sustained VT/VF.
Unlike many of the risk factors for sudden cardiac death, physical
activity is a modifiable risk factor. Reductions in heart failure risk are
seen among patients adhering to guideline-recommended levels of
activity.16 The recommended level of 150-300 minutes of moderately
intense activity per week may seem out of reach for many heart fail-
ure patients; however, even modest increases in physical activity can
have beneficial cardiac outcomes.17 Studies of heart failure patients
participating in short-term cardiac rehabilitation programs have shown
significant improvements in peak oxygen uptake and left ventricular
ejection fraction.18,19
TABLE 1 Baseline characteristics by group
Total sample Shocked Nonshocked P-value
N (%) 4057 81 (2) 3976 (98)
Age mean (SD) 60 (13) 64 (14) 60 (13) .01
Male (%) 3239 (80) 67 (83) 3172 (80) .51
Daily step count week 1 median (IQR) 4771 (2739-7318) 2456 (961-4185) 4821 (2779-7350) <.001
WCD indication (%) <.001
Recent PCI 1182 (29.1) 23 (28.4) 1159 (29.1)
Dilated cardiomyopathy 1007 (24.8) 8 (9.9) 999 (25.1)
Other 952 (23.5) 25(30.9) 927 (23.3)
NICM 364 (9.0) 4(4.9) 360 (9.1)
Myocarditis 242 (6.0) 5(6.2) 237 (6.0)
ICD explant 163 (4.0) 13(16.0) 150 (3.8)
Recent CABG 147 (3.6) 3(3.7) 144 (3.6)
ICD, implantable cardioverter defibrillator; IQR, interquartile range; NICM, nonischemic cardiomyopathy; PCI, percutaneous coronary intervention; SD,
standard deviation; WCD, wearable cardioverter defibrillator.
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The current study presents physical activity as a function of step
count. Studies from North American and Australia report 20-35% of a
population-based sample of adults own a wearable activity
tracker.20,21 The ubiquity of commercially available step count moni-
tors makes this metric of activity more accessible for patients than the
traditionally reported minutes spent active. A systematic review of
26 studies found activity tracker utilization was associated with signif-
icant improvements in physical activity among outpatient adults.22
Among post-myocardial infarction patents, activity self-monitoring
was associated with exercise maintenance 6 months after completing
a cardiac rehabilitation program compared to a randomized nonself-
monitoring group.23 These studies suggest objective monitoring of
daily activity empowers patients to engage in their own activity reha-
bilitation process. Outcomes from the current study allow clinicians to
encourage patients to set specific, evidence-based activity goals and
use activity trackers to monitor progress towards these goals.
The ubiquity of patient owned activity trackers and the increased
available of cardiac devices with accelerometer recorded activity that
can be provided to physicians increases the utility of activity metrics
for monitoring cardiac care. Changes in activity may signal declining
health and worsening heart failure. Accelerometer containing cardiac
devices, including the WCD, can provide continuous real-time activity
monitoring of at-risk patients. The present study suggests reduced
activity may be a useful marker to identify patients at increased risk of
sustained VT/VF, further adding to sudden cardiac death risk stratifi-
cation beyond left ventricular ejection fraction. Others have proposed
the presence of warning symptoms and signs, such as angina pectoris
and dyspnea that may forecast sudden cardiac arrest.24-26 Identifica-
tion of a decline in activity as a precedent to sustained VT/VF may
allow physicians time to intervene and make pharmacological or other
treatment adjustments.
4.1 | Study limitations
The retrospective design of this study does not allow for a causal con-
clusion to be drawn between decreased activity and sustained
VT/VF. It remains a possibility that patients who are less active are
sicker and therefore at a greater risk of death. However, in the
MADIT-CRT, reduced activity during the week of a nonfatal ventricu-
lar arrhythmia was associated with an increased probability of death.7
These findings suggest a decline in physical activity may precede
sustained VT/VF, and that decreased activity associated with VT/VF
may determine the significance of the event for future outcomes,
including death. Prospective studies would be helpful to determine
the possible benefit of physical activity in preventing sudden cardiac
death. In addition, randomization based on disease state would pro-
vide information about the relationship between change in physical
activity and heart failure progression.
A second limitation of this study is the lack of co-variates, includ-
ing underlying heart disease, mobility restrictions, pharmacological
management, and NYHA class, all of which may influence a proportion
of the relationship found between decreased activity and increased
incidence of shock. The study sample, although large in number, was
pulled from a commercial database with limited co-variate data avail-
able for reporting. Another limitation, similar to many other cardiac
study populations, our sample was predominately male. A significant
gender difference in rates of physical activity may exist.
F IGURE 1 Daily average step count
across the 4-week study period. Step
count was significantly lower in the
appropriately shocked compared to
nonshocked group across each of the
4 weeks
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An international study of 3572 acute-myocardial infarction
(MI) patients found women were 37% more likely to exhibit low levels
of activity compared to males.27 At 12 months post-MI, only 36% of
women compared to 48% of men met the recommended level of
physical activity. Encouragingly, a meta-analysis including 370 460
heart failure patients found the benefit of higher levels of physical
activity in reducing heart failure risk was similar between men and
women.28 Though men and women may benefit from physical activity,
additional investigation is needed to determine if the cutoff values in
activity detected from predominately male cardiac populations are
applicable to female patients.
Engaging in regular physical activity is critical for optimal heart
failure management. Patients who manifest spontaneous VT/VF have
a lower average daily step count than those who do not have a
sustained VT/VF event. Among patients at risk for sudden cardiac
arrest, encouraging a minimum of 4000 steps per day could reduce
the likelihood of sustained VT/VF.
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